Page last updated: 2024-10-24

pH reduction

Definition

Target type: biologicalprocess

Any process that reduces the internal pH of an organism, part of an organism or a cell, measured by the concentration of the hydrogen ion. [GOC:go_curators]

pH reduction, also known as acidification, is a fundamental biological process that involves lowering the pH of a solution. It occurs in various physiological contexts and is crucial for diverse biological functions.

The reduction of pH involves an increase in the concentration of hydrogen ions (H+) in a solution. This can occur through several mechanisms:

1. **Production of Acids:** Many biological processes generate acids, such as carbon dioxide (CO2) production during cellular respiration. CO2 dissolves in water to form carbonic acid (H2CO3), which then dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3-). Other acids, like lactic acid and uric acid, are also produced as byproducts of metabolic activities.

2. **Proton Pumps:** Cellular membranes contain proton pumps that actively transport hydrogen ions across the membrane, effectively increasing the concentration of H+ in a specific compartment. This mechanism is particularly important in processes like oxidative phosphorylation and the generation of electrochemical gradients.

3. **Hydrolysis of Acidic Compounds:** The breakdown of certain molecules, like ATP, releases hydrogen ions. These ions can contribute to the overall acidification of the solution.

4. **Release of Acidic Metabolites:** Some organisms, like bacteria, can release acidic metabolites into their surrounding environment as part of their metabolic processes.

**Biological Significance of pH Reduction:**

1. **Enzymatic Activity:** Many enzymes have optimal pH ranges for their activity. Reducing pH can alter the conformation and activity of enzymes, influencing metabolic pathways and cellular processes.

2. **Digestion:** The acidic environment in the stomach is crucial for the breakdown of food, particularly protein digestion. The low pH activates pepsin, a protease that breaks down proteins into smaller peptides.

3. **Cellular Respiration:** The proton gradient generated by the electron transport chain in mitochondria is essential for ATP production. This gradient is established through the pumping of protons across the inner mitochondrial membrane.

4. **Waste Removal:** The kidneys regulate pH balance in the body by excreting excess acids in the urine.

5. **Defense Mechanisms:** Some organisms produce acids as a defense mechanism against predators or pathogens.

**Disruption of pH Balance:**

A significant deviation from the optimal pH range can disrupt cellular functions and lead to pathological conditions. Acidosis, a condition characterized by low blood pH, can occur due to various factors like respiratory problems, diabetes, or kidney disease. It can disrupt the function of organs and systems, potentially leading to serious complications.

Overall, pH reduction is a fundamental biological process that plays a vital role in numerous physiological functions. Maintaining proper pH balance is crucial for cellular health and overall well-being.'"

Proteins (3)

ProteinDefinitionTaxonomy
Potassium-transporting ATPase subunit betaA potassium-transporting ATPase subunit beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51164]Homo sapiens (human)
Gastrin/cholecystokinin type B receptorA cholecystokinin receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P32239]Homo sapiens (human)
Potassium-transporting ATPase alpha chain 1A potassium-transporting ATPase alpha chain 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P20648]Homo sapiens (human)

Compounds (31)

CompoundDefinitionClassesRoles
5-methoxytryptamine5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.

5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
aromatic ether;
primary amino compound;
tryptamines
5-hydroxytryptamine 2A receptor agonist;
5-hydroxytryptamine 2B receptor agonist;
5-hydroxytryptamine 2C receptor agonist;
antioxidant;
cardioprotective agent;
human metabolite;
mouse metabolite;
neuroprotective agent;
radiation protective agent;
serotonergic agonist
cimetidinecimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
aliphatic sulfide;
guanidines;
imidazoles;
nitrile
adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
omeprazole5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
ranitidinearalkylamine
indopanalpha-methyltryptamine : A tryptamine derivative having a methyl substituent at the alpha-position.

indopan: RN given refers to parent cpd without isomeric designation
tryptamines
5-methoxy-alpha-methyltryptamine5-methoxy-alpha-methyltryptamine: RN given refers to parent cpd without isomeric designationtryptamines
spiroglumidespiroglumide: a CCK receptor antagonist; antigastrin; structure given in first source
timoprazoletimoprazole: gastric acid secretion inhibitor
Pyrrolidine-1-carbonitrilepyrrolidines
enkephalin, d-penicillamine (2,5)-DPDPE : A heterodetic cyclic peptide that is a cyclic enkephalin analogue, having D-penicillaminyl residues located at positions 2 and 5, which form the heterocycle via a disulfide bond.

Enkephalin, D-Penicillamine (2,5)-: A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity.
heterodetic cyclic peptidedelta-opioid receptor agonist
ci 988PD 134308: selective cholecystokinin type B receptor antagonist; inhibits growth of LoVo, a human colon cancer cell line; structure given in first source
2-((2-dimethylaminobenzyl)sulfinyl)benzimidazole2-((2-dimethylaminobenzyl)sulfinyl)benzimidazole: structure given in first source
l 740093L 740093: a CCK-B receptor antagonist; structure in first source
cholecystokinin 9cholecystokinin 9: nonapeptide
devazepidedevazepide : An indolecarboxamide obtained by formal condensation of the carboxy group of indole-2-carboxylic acid with the exocyclic amino group of (3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one. A cholecystokinin antagonist used for treatment of gastrointestinal disorders.

Devazepide: A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
1,4-benzodiazepinone;
indolecarboxamide
antineoplastic agent;
apoptosis inducer;
cholecystokinin antagonist;
gastrointestinal drug
tetragastrintetragastrin : A tetrapeptide composed of L-tryptophan, L-methione, L-aspartic acid and L-phenylalaninamide residues joined in sequence.

Tetragastrin: L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin.
peptidyl amide;
tetrapeptide
anxiogenic;
human metabolite
cholecystokinin (26-33)cholecystokinin (26-33): cholecystokinin receptor antagonists
cholecystokinin (27-33), tert-butyloxycarbonyl-nle(28,31)-cholecystokinin (27-33), tert-butyloxycarbonyl-Nle(28,31)-: cholecystokinin agonist
2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone2-(2-(5-bromo-1H-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3H)-quinazolinone: CCK2 receptor antagonistquinazolines
l 365260L 365260: a CCK-B antagonist; structure given in first source; potent & selective CCK-B & gastrin receptor ligand; L 365260 and L 365346 are (R)- and (S)-stereoisomers, respectivelybenzodiazepine
enkephalin, ala(2)-mephe(4)-gly(5)-peptide
sincalideSincalide: An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas.oligopeptide
pentagastrinPentagastrin: A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.organic molecular entity
yf 476YF 476: gastrin and CCK-B receptor antagonist; structure in first source
l 365260
mart-1 antigenMART-1 Antigen: A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride
naluzotannaluzotan: an antidepressant and anti-anxiety agent; structure in first source
butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide
gastrin 17gastrin-17 : One of the primary forms of gastrin that is a 17-membered peptide consisting of Glp, Gly, Pro, Trp, Leu, Glu, Glu, Glu, Glu, Glu, Ala, Tyr, Gly, Trp, Met, Asp and Phe-NH2 residues joined in sequence.gastrinantineoplastic agent
nitd 609NITD 609: an antimalarial and coccidiostat; structure in first source